Log In
BCIQ
Print this Print this
 

PEG-EPO

  Manage Alerts
Collapse Summary General Information
Company PharmaEssentia Corp.
DescriptionPegylated erythropoietin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationAnemia
Indication DetailsTreat anemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today